Taking melatonin for a year could increase a person's risk of developing heart failure by 90%. While more research is still needed to confirm these findings, the data suggest patients should think twice about relying on melatonin to sleep.
Novo Nordisk and Eli Lilly have agreed to sell their popular Wegovy and Zepbound injectables through TrumpRx.gov for a discounted rate, as the White House promises that Medicaid and Medicare plans will begin covering the costs.
Authorities said in a court filing that they received a complaint about Northeast Ohio Neighborhood Health Services’ business practices. The health system owes more than $12 million to creditors, and investigators are asking to see its financial records.
The company will analyze claims data from over 2 million people enrolled in Medi-Cal. The data will be used for compliance reporting and to improve patient care coordination.
SIR contends that payments toward transarterial radioembolization (TARE)/selective internal radiation therapy (SIRT) should extend beyond the current coverage limitations in patients with liver cancer and metastases.
The product is a fully integrated, artificial intelligence-enabled technology tool, providing real-time analytics to interested outside radiology groups.
The findings are from research conducted by the Commonwealth Fund that looked at nationwide provider reimbursement data. While the sample size is small, it shows the insurer tends to favor its own doctors.
A federal judge dismissed a lawsuit from Texas Attorney General Ken Paxton, who sought an injunction against abortion medications being shipped to women in his state.
The global artifical intelligence leader collaborated with the NIH, Children’s Hospital of Philadelphia, and VinBrain to create the new chain-of-thought dataset.
Taking melatonin for a year could increase a person's risk of developing heart failure by 90%. While more research is still needed to confirm these findings, the data suggest patients should think twice about relying on melatonin to sleep.
